Literature DB >> 8930075

Association of BoLA class II haplotypes with subclinical progression of bovine leukaemia virus infection in Holstein-Friesian cattle.

M Zanotti1, G Poli, W Ponti, M Polli, M Rocchi, E Bolzani, M Longeri, S Russo, H A Lewin, M J van Eijk.   

Abstract

The influence of bovine lymphocyte antigen (BoLA) complex polymorphism on subclinical progression of bovine leukaemia virus (BLV) infection was investigated in 41 Holstein-Friesian cows from two herds in Italy. All cows were seropositive for BLV and 22 had persistent lymphocytosis (PL). BoLA-A specificities were defined by serology, and class II haplotypes were defined based on restriction fragment length polymorphism (RFLP) and polymerase chain reaction (PCR)-RFLP analysis of DQ and DR genes. Chi-square analysis revealed a significant and absolute association of haplotype DQA*3A-DQB*3A-DRB2*2A-DRB3.2*11 with resistance to PL (P chi 2 = 0.028, relative risk (RR) = 0.061). Consistent with this observation, multiple regression analysis revealed that animals carrying this haplotype had lower lymphocyte counts (P = 0.0057). By contrast, haplotype DQA*12-DQB*12-DRB2*3A-DRB3.2*8 was associated with susceptibility to PL (P chi 2 = 0.043, RR = 9.625) and increased lymphocyte counts (P = 0.0537). These results confirm the association of haplotype DQA*3A-DQB*3A-DRB2*2A-DRB3.2*11 with resistance to PL, and substantiate earlier findings of haplotype DQA*12-DQB*12-DRB2*3A-DRB3.2*8 as a risk factor for subclinical progression to PL in BLV-infected Holstein-Friesian cattle.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8930075

Source DB:  PubMed          Journal:  Anim Genet        ISSN: 0268-9146            Impact factor:   3.169


  13 in total

1.  Breadth of the CD4+ T cell response to Anaplasma marginale VirB9-1, VirB9-2 and VirB10 and MHC class II DR and DQ restriction elements.

Authors:  Kaitlyn Morse; Junzo Norimine; Jayne C Hope; Wendy C Brown
Journal:  Immunogenetics       Date:  2012-02-24       Impact factor: 2.846

2.  gammadelta(+) T-Lp6phocyte cytotoxicity against envelope-expressing target cells is unique to the alymphocytic state of bovine leukemia virus infection in the natural host.

Authors:  P Lundberg; G A Splitter
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  The effect of bovine viral diarrhea virus on bovine monocyte phenotype.

Authors:  K S Choi
Journal:  Iran J Vet Res       Date:  2017       Impact factor: 1.376

4.  Bovine leukocyte antigen major histocompatibility complex class II DRB3*2703 and DRB3*1501 alleles are associated with variation in levels of protection against Theileria parva challenge following immunization with the sporozoite p67 antigen.

Authors:  Keith T Ballingall; Anthony Luyai; G John Rowlands; Jill Sales; Anthony J Musoke; Subash P Morzaria; Declan J McKeever
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

5.  BoLA-DRB3 gene polymorphism and FMD resistance or susceptibility in Wanbei cattle.

Authors:  Wei Lei; Qinglong Liang; Luo Jing; Chengmin Wang; Xiaobing Wu; Hongxuan He
Journal:  Mol Biol Rep       Date:  2012-06-29       Impact factor: 2.316

Review 6.  Preventive and therapeutic strategies for bovine leukemia virus: lessons for HTLV.

Authors:  Sabrina M Rodríguez; Arnaud Florins; Nicolas Gillet; Alix de Brogniez; María Teresa Sánchez-Alcaraz; Mathieu Boxus; Fanny Boulanger; Gerónimo Gutiérrez; Karina Trono; Irene Alvarez; Lucas Vagnoni; Luc Willems
Journal:  Viruses       Date:  2011-07-19       Impact factor: 5.048

Review 7.  Bovine mastitis: frontiers in immunogenetics.

Authors:  Kathleen Thompson-Crispi; Heba Atalla; Filippo Miglior; Bonnie A Mallard
Journal:  Front Immunol       Date:  2014-10-07       Impact factor: 7.561

8.  The major histocompatibility complex in bovines: a review.

Authors:  Jyotsna Dhingra Behl; N K Verma; Neha Tyagi; Priyanka Mishra; Rahul Behl; B K Joshi
Journal:  ISRN Vet Sci       Date:  2012-05-28

Review 9.  Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human.

Authors:  Nicolas Gillet; Arnaud Florins; Mathieu Boxus; Catherine Burteau; Annamaria Nigro; Fabian Vandermeers; Hervé Balon; Amel-Baya Bouzar; Julien Defoiche; Arsène Burny; Michal Reichert; Richard Kettmann; Luc Willems
Journal:  Retrovirology       Date:  2007-03-16       Impact factor: 4.602

Review 10.  Mechanisms of pathogenesis induced by bovine leukemia virus as a model for human T-cell leukemia virus.

Authors:  Yoko Aida; Hironobu Murakami; Masahiko Takahashi; Shin-Nosuke Takeshima
Journal:  Front Microbiol       Date:  2013-11-08       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.